Share:
Although drug resistance to second-generation integrase inhibitors is still relatively uncommon, this is a serious risk that needs expert management, usually as part of a multi-disciplinary team.
Read the full report by Simon Collins, HIV i-Base here.
Source : HIV i-Base
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.